Author:
Haskova Zdenka,Whitacre Margaret N.,Dede Kimberly A.,Lee Judithann M.,Trulli Stephen H.,Ciucci Marc,Toso John F.,White John R.,Jonak Zdenka L.
Reference10 articles.
1. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives;Aivado;Seminars in Oncology,2002
2. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases;Chow;Haematologica,2002
3. Bendamustine in chronic lymphocytic leukemia: the future is combination therapy;Friedberg;Leukaemia & Lymphoma,2009
4. In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling;de Haij;Cancer Research,2010
5. State-of-the-art treatment of chronic lymphocytic leukemia;Hallek;Hematology American Society of Hematology Education Program,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献